Last reviewed · How we verify
Cutaneous anthrax
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Doxycyclin · Bulovka Hospital
- Penicillin G Potassium In Plastic Container · Pfizer
- Vibramycin · Generic (originally Pfizer)
- penicillin · Karlstad University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Cutaneous anthrax patent landscape — cliff calendar, originator estates, attackable patents
- Cutaneous anthrax treatment landscape brief
- Cutaneous anthrax treatment updates RSS
Frequently asked questions about Cutaneous anthrax
What drugs treat Cutaneous anthrax?
Tracked treatments include Ramycin, Doxycyclin, Penicillin G Potassium In Plastic Container, Vibramycin, penicillin.
What is the treatment for Cutaneous anthrax?
Standard treatment for Cutaneous anthrax includes Ramycin, Doxycyclin, Penicillin G Potassium In Plastic Container, Vibramycin, penicillin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Cutaneous anthrax patent cliff · Cutaneous anthrax CI report
- Treatment: Ramycin
- Treatment: Doxycyclin · Bulovka Hospital
- Treatment: Penicillin G Potassium In Plastic Container · Pfizer
- Treatment: Vibramycin · Generic (originally Pfizer)
- Treatment: penicillin · Karlstad University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing